The correlation of left ventricular hypertrophy with the severity of atherosclerosis and embolic events

Nattawut Wongpraparut1, Sirin Apiyasawat, Suraj Maraj

  • 1Division of Cardiovascular Disease, Department of Medicine, Albert Einstein Medical Center, 363 Klein Professional Building, 5401 Old York Road, Philadelphia, PA 19141, USA.

Insights

Left ventricular mass index correlates with aortic atheroma severity. Increased LV mass and plaque severity are linked to stroke, highlighting cardiovascular risk in patients with higher left ventricular mass.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Cardiac Imaging

Background:

  • Aortic atheroma is a marker of systemic atherosclerosis.
  • Left ventricular (LV) mass index reflects cardiac remodeling.
  • The relationship between aortic plaque and LV hypertrophy requires further elucidation.

Purpose of the Study:

  • To assess the correlation between aortic atheroma and LV mass index.
  • To investigate the association between aortic plaque characteristics and clinical outcomes.
  • To understand the contribution of LV mass to cardiovascular risk.

Main Methods:

  • Retrospective analysis of 87 patients with aortic atherosclerosis and controls.
  • Transesophageal echocardiography (TEE) data from 1995-2000.
  • Comparison of LV mass index and aortic plaque severity between groups.

Main Results:

  • Mean LV mass index was significantly higher in the atherosclerosis group (116 g/m²) versus controls (81 g/m²).
  • A close correlation was observed between LV mass index and the severity of aortic arch and descending aorta plaque.
  • Large, ulcerated plaques showed a significant correlation with stroke events (p < 0.002).

Conclusions:

  • LV mass index is a significant correlate of aortic atheroma severity.
  • Smoking, hypertension, and high LV mass index are associated with severe plaque and stroke.
  • Increased LV mass may partially explain the elevated cardiovascular risk in affected patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...